Stay updated on AG-270 in Solid Tumors/Lymphoma with MTAP Loss Clinical Trial
Sign up to get notified when there's something new on the AG-270 in Solid Tumors/Lymphoma with MTAP Loss Clinical Trial page.

Latest updates to the AG-270 in Solid Tumors/Lymphoma with MTAP Loss Clinical Trial page
- Check3 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 on the page. This appears to be a software/version update and does not alter study content.SummaryDifference0.0%

- Check10 days agoChange DetectedAdded a glossary toggle to show glossary on the page. Minor label capitalization changes for QC-related text and a new revision tag (v3.4.0).SummaryDifference0.2%

- Check17 days agoChange DetectedKey study documentation and explanatory materials were removed from the page, including the lay summary, informed consent form, SAP, study protocol, IPD sharing information, and the Clinical Study Report. This reduces access to essential details about the study design, participant protections, and data-sharing terms.SummaryDifference21%

- Check24 days agoChange DetectedRevision: v3.3.4 appears on the page, replacing the previous v3.3.3. This looks like a site version update with no impact on the study details.SummaryDifference0.0%

- Check45 days agoChange DetectedLocations section added: Connecticut, Massachusetts, New York, and Tennessee; HHS Vulnerability Disclosure link removed.SummaryDifference0.4%

- Check74 days agoChange DetectedPublication section text updated to reflect PubMed auto-fill and a new revision stamp v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to AG-270 in Solid Tumors/Lymphoma with MTAP Loss Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AG-270 in Solid Tumors/Lymphoma with MTAP Loss Clinical Trial page.